Clinical research

Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registries

EuroIntervention 2013;9:452-462. DOI: 10.4244/EIJV9I4A74

Anouska Moynagh
Anouska Moynagh1, MD; Neus Salvatella1, MD; Talal Harb1, MD; Olivier Darremont2, MD; Nicolas Boudou2, MD; Nicolas Dumonteil2, MD; Thierry Lefèvre1, MD; Didier Carrié3, MD, PhD; Yves Louvard1, MD; Jean-Louis Leymarie1, MD; Bernard Chevalier1, MD; Marie-Claude Morice1, MD; Philippe Garot1*, MD
1. Institut Jacques Cartier and Hopital Claude Galien, Institut Cardiovasculaire Paris Sud, Massy and Quincy, France; 2. Clinique Saint-Augustin, Bordeaux, France; 3. CHU Toulouse Rangueil, Toulouse, France

Aims: With newer drug-eluting stents (DES), PCI has appeared as an acceptable alternative to cardiac surgery in the treatment of unprotected lef

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

coronary artery diseaseoutcomesstentingunprotected left main
Read next article
New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN® device in patients not taking warfarin

Latest news